Self-management education for cystic fibrosis by Savage, Eileen et al.
Title Self-management education for cystic fibrosis
Author(s) Savage, Eileen; Beirne, Paul V.; Ní Chróinín, Muireann; Duff, Alistair;
Fitzgerald, Anthony P.; Farrell, Dawn
Publication date 2011-07
Original citation SAVAGE, E., BEIRNE PAUL, V., NI CHROININ, M., DUFF, A.,
FITZGERALD, T. & FARRELL, D. 2011. Self-management education
for cystic fibrosis. Cochrane Database of Systematic Reviews 2011,
Issue 7, Art. No.:CD007641. DOI:
http://dx.doi.org/10.1002/14651858.CD007641.pub2
Type of publication Article (peer-reviewed)
Link to publisher's
version
http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD0
07641/frame.html
http://dx.doi.org/10.1002/14651858.CD007641.pub2
Access to the full text of the published version may require a
subscription.
Rights Copyright © 2011 The Cochrane Collaboration. Published by John
Wiley & Sons, Ltd.This review is published as a Cochrane Review in
the Cochrane Database of Systematic Reviews 2011, Issue 7.
Cochrane Reviews are regularly updated as new evidence emerges
and in response to comments and criticisms, and the Cochrane
Database of Systematic Reviews should be consulted for the most
recent version of the Review.’ SAVAGE, E., BEIRNE PAUL, V., NI
CHROININ, M., DUFF, A., FITZGERALD, T. & FARRELL, D.
2011. Self-management education for cystic fibrosis. Cochrane
Database of Systematic Reviews 2011, Issue 7, Art. No.:CD007641.
DOI: http://dx.doi.org/10.1002/14651858.CD007641.pub2
Item downloaded
from
http://hdl.handle.net/10468/608
Downloaded on 2017-02-12T07:07:29Z
Self-management education for cystic fibrosis (Review)
Savage E, Beirne PV, Ni Chroinin M, Duff A, Fitzgerald T, Farrell D
This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library
2011, Issue 7
http://www.thecochranelibrary.com
Self-management education for cystic fibrosis (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Figure 2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
18DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
21AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
21ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
22REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
26CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
40DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 Self-management training versus standard treatment, Outcome 1 Change in weight
(Children). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Analysis 1.2. Comparison 1 Self-management training versus standard treatment, Outcome 2 Number of digestive system
self-management behaviours (Children). . . . . . . . . . . . . . . . . . . . . . . . . 44
Analysis 1.3. Comparison 1 Self-management training versus standard treatment, Outcome 3 Number of pulmonary
system self-management behaviours (Children). . . . . . . . . . . . . . . . . . . . . . . 44
Analysis 1.4. Comparison 1 Self-management training versus standard treatment, Outcome 4 Frequency of digestive system
self-management behaviours (Children). . . . . . . . . . . . . . . . . . . . . . . . . 45
Analysis 1.5. Comparison 1 Self-management training versus standard treatment, Outcome 5 Frequency of pulmonary
system self-management behaviours (Children). . . . . . . . . . . . . . . . . . . . . . . 45
Analysis 1.6. Comparison 1 Self-management training versus standard treatment, Outcome 6 Total frequency of digestive
and pulmonary self-management behaviours (Children). . . . . . . . . . . . . . . . . . . . 46
Analysis 1.7. Comparison 1 Self-management training versus standard treatment, Outcome 7 Adherence - percentage of
prescribed medications taken by children. . . . . . . . . . . . . . . . . . . . . . . . . 46
Analysis 1.8. Comparison 1 Self-management training versus standard treatment, Outcome 8 Adherence - percentage of
prescribed aerosol treatment taken by children. . . . . . . . . . . . . . . . . . . . . . . 47
Analysis 1.9. Comparison 1 Self-management training versus standard treatment, Outcome 9 Adherence - percentage of
prescribed chest physiotherapy treatment taken by children. . . . . . . . . . . . . . . . . . . 47
Analysis 1.10. Comparison 1 Self-management training versus standard treatment, Outcome 10 Knowledge of cystic
fibrosis and its management (Children). . . . . . . . . . . . . . . . . . . . . . . . . . 48
Analysis 1.11. Comparison 1 Self-management training versus standard treatment, Outcome 11 Quality of well-being
(Children). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
Analysis 1.12. Comparison 1 Self-management training versus standard treatment, Outcome 12 Number of digestive
system self-management behaviours (Parents). . . . . . . . . . . . . . . . . . . . . . . . 49
Analysis 1.13. Comparison 1 Self-management training versus standard treatment, Outcome 13 Number of pulmonary
system self-management behaviours (Parents). . . . . . . . . . . . . . . . . . . . . . . . 49
Analysis 1.14. Comparison 1 Self-management training versus standard treatment, Outcome 14 Total number of digestive
and pulmonary self-management behaviours (Parents). . . . . . . . . . . . . . . . . . . . . 50
Analysis 1.15. Comparison 1 Self-management training versus standard treatment, Outcome 15 Frequency of digestive
system self-management behaviours (Parents). . . . . . . . . . . . . . . . . . . . . . . . 50
Analysis 1.16. Comparison 1 Self-management training versus standard treatment, Outcome 16 Frequency of pulmonary
system self-management behaviours (Parents). . . . . . . . . . . . . . . . . . . . . . . . 51
Analysis 1.17. Comparison 1 Self-management training versus standard treatment, Outcome 17 Total frequency of digestive
and pulmonary system self-management behaviours (Parents). . . . . . . . . . . . . . . . . . 51
Analysis 1.18. Comparison 1 Self-management training versus standard treatment, Outcome 18 Knowledge of cystic
fibrosis and its management (Parents). . . . . . . . . . . . . . . . . . . . . . . . . . 52
iSelf-management education for cystic fibrosis (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.1. Comparison 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus
standard treatment, Outcome 1 Adherence - percentage of prescribed aerosol treatment taken by children. . . 52
Analysis 2.2. Comparison 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus
standard treatment, Outcome 2 Adherence - percentage of airway clearance treatments taken by children. . . 53
Analysis 2.3. Comparison 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus
standard treatment, Outcome 3 Knowledge of aerosol and airway clearance treatments (Children). . . . . 53
Analysis 2.4. Comparison 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus
standard treatment, Outcome 4 Self management assessment behaviours (Caregivers). . . . . . . . . . 54
Analysis 2.5. Comparison 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus
standard treatment, Outcome 5 Self-management treatment behaviour (Caregivers). . . . . . . . . . 54
Analysis 2.6. Comparison 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus
standard treatment, Outcome 6 Self-management communication behaviour (Caregivers). . . . . . . . 55
Analysis 2.7. Comparison 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus
standard treatment, Outcome 7 Self management responsiveness to airway clearance treatment when child unwell
(Caregivers). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
Analysis 2.8. Comparison 2 Self-management education on aerosol and airway clearance treatments (’Airways’) versus
standard treatment, Outcome 8 Self efficacy (Caregivers). . . . . . . . . . . . . . . . . . . . 56
Analysis 3.1. Comparison 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment,
Outcome 1 Appropriate self-management of malabsorption (Children). . . . . . . . . . . . . . . 56
Analysis 3.2. Comparison 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment,
Outcome 2 Inappropriate self-management of malabsorption (Children). . . . . . . . . . . . . . 57
Analysis 3.3. Comparison 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment,
Outcome 3 Knowledge of nutrition and enzymes (Children). . . . . . . . . . . . . . . . . . 57
Analysis 3.4. Comparison 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment,
Outcome 4 Appropriate self-management of malabsorption (Caregivers). . . . . . . . . . . . . . 58
Analysis 3.5. Comparison 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment,
Outcome 5 Inappropriate self-management of malabsorption (Caregivers). . . . . . . . . . . . . . 58
Analysis 3.6. Comparison 3 Disease-specific nutrition education (’Go and Grow with CF’) versus standard treatment,
Outcome 6 Knowledge of malabsorption and vitamins (Caregivers). . . . . . . . . . . . . . . . 59
Analysis 4.1. Comparison 4 General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment,
Outcome 1 Per cent predicted FEV1. . . . . . . . . . . . . . . . . . . . . . . . . . . 59
Analysis 4.2. Comparison 4 General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment,
Outcome 2 Weight. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
Analysis 4.3. Comparison 4 General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment,
Outcome 3 Dietary fat intake. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
Analysis 4.4. Comparison 4 General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment,
Outcome 4 Self efficacy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
Analysis 4.5. Comparison 4 General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment,
Outcome 5 Knowledge of cystic fibrosis disease-specific nutrition. . . . . . . . . . . . . . . . . 61
Analysis 4.6. Comparison 4 General and disease-specific nutrition education (’Eat Well with CF’) versus standard treatment,
Outcome 6 Knowledge of general nutrition. . . . . . . . . . . . . . . . . . . . . . . . 62
62APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
65HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
66CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
66DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
66SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
67DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
67INDEX TERMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iiSelf-management education for cystic fibrosis (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Self-management education for cystic fibrosis
Eileen Savage1, Paul V Beirne2, Muireann Ni Chroinin3, Alistair Duff4, Tony Fitzgerald2, Dawn Farrell5
1Catherine McAuley School of Nursing & Midwifery Brookfield Health Sciences Complex, University College Cork, Cork, Ireland.
2Department of Epidemiology and Public Health, University College Cork, Cork, Ireland. 3Division of Children’s Services, Cork
University Hospital, Cork, Ireland. 4Department of Clinical & Health Psychology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
5School of Nursing & Midwifery, Brookfield Health Sciences, University College Cork, Cork, Ireland
Contact address: Eileen Savage, Catherine McAuley School of Nursing & Midwifery Brookfield Health Sciences Complex, University
College Cork, Cork, Ireland. e.savage@ucc.ie.
Editorial group: Cochrane Cystic Fibrosis and Genetic Disorders Group.
Publication status and date: New, published in Issue 7, 2011.
Review content assessed as up-to-date: 6 June 2011.
Citation: Savage E, Beirne PV,Ni ChroininM, Duff A, Fitzgerald T, Farrell D. Self-management education for cystic fibrosis. Cochrane
Database of Systematic Reviews 2011, Issue 7. Art. No.: CD007641. DOI: 10.1002/14651858.CD007641.pub2.
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Self-management education may help patients with cystic fibrosis and their families to choose, monitor and adjust treatment require-
ments for their illness, and also to manage the effects of illness on their lives. Although self-management education interventions
have been developed for cystic fibrosis, no previous systematic review of the evidence of effectiveness of these interventions has been
conducted.
Objectives
To assess the effects of self-management education interventions on improving health outcomes for patients with cystic fibrosis and
their caregivers
Search strategy
We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register (date of the last search: 23 February 2011).
We also searched databases through EBSCO (CINAHL; Psychological and Behavioural Sciences Collection; PsychInfo; SocINDEX)
and Elsevier (EMBASE) and handsearched relevant journals and conference proceedings (date of the last searches: 30th March 2011).
Selection criteria
Randomised controlled trials, quasi-randomised controlled trials or controlled clinical trials comparing different types of self-manage-
ment education for cystic fibrosis or comparing self-management education with standard care or no intervention.
Data collection and analysis
Two authors assessed trial eligibility and risk of bias. Three authors extracted data.
Main results
Four trials (involving a total of 269 participants) were included. The participants were children with cystic fibrosis and their parents
or caregivers in three trials and adults with cystic fibrosis in one trial. The trials compared four different self-management education
interventions versus standard treatment: (1) a training programme for managing cystic fibrosis in general; (2) education specific to
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aerosol and airway clearance treatments; (3) disease-specific nutrition education; and (4) general and disease-specific nutrition education.
Training children to manage cystic fibrosis in general had no statistically significant effects on weight after six to eight weeks, mean
difference -7.74 lb (95% confidence interval -35.18 to 19.70). General and disease-specific nutrition education for adults had no
statistically significant effects on: pulmonary function (forced expiratory volume at one second), mean difference -5.00 % (95%
confidence interval -18.10 to 8.10) at six months and mean difference -5.50 % (95% confidence interval -18.46 to 7.46) at 12 months;
or weight, mean difference - 0.70 kg (95% confidence interval -6.58 to 5.18) at six months and mean difference -0.70 kg (95%
confidence interval -6.62 to 5.22) at 12 months; or dietary fat intake scores, mean difference 1.60 (85% confidence interval -2.90 to
6.10) at six months and mean difference 0.20 (95% confidence interval -4.08 to 4.48) at 12 months. There is some limited evidence
to suggest that self-management education may improve knowledge in patients with cystic fibrosis but not in parents or caregivers.
There is also some limited evidence to suggest that self-management education may result in positively changing a small number of
behaviours in both patients and caregivers.
Authors’ conclusions
The available evidence from this review is of insufficient quantity and quality to draw any firm conclusions about the effects of self-
management education for cystic fibrosis. Further trials are needed to investigate the effects of self-management education on a range
of clinical and behavioural outcomes in children, adolescents and adults with cystic fibrosis and their caregivers.
P L A I N L A N G U A G E S U M M A R Y
Self-management education for cystic fibrosis
We set out to review the effects of self-management education for cystic fibrosis on a range of health outcomes in individuals of all ages
with cystic fibrosis and their caregivers. Our search for available evidence identified four trials, and all four compared a form of self-
management education to standard treatment. The precise focus of self management differed between trials and included a training
programme for managing cystic fibrosis, education on chest treatments, education on nutrition specific to cystic fibrosis, and education
on general and disease-specific nutrition. Self-management education had no positive effects on lung function, weight, or intake of fatty
food. There is some evidence to suggest that self-management education improves knowledge about cystic fibrosis and its management
in patients with this condition and some self-management behaviours in patients and caregivers. However, due to the small number
of trials in this review, and because of concerns about the quality of these trials, we are unable to reach any firm conclusions about the
effects of self-management education for cystic fibrosis. We recommend that further trials are conducted to evaluate the effects of self-
management education interventions.
B A C K G R O U N D
Description of the condition
Cystic fibrosis (CF) is the most common life-limiting, autosomal
recessively inherited disease in Caucasian populations with an es-
timated incidence of 1 per 3000 births per annum (Walters 2007).
Most individuals are diagnosed in their first year of life and many
countries now have newborn screening programmes. The disease
manifests as pancreatic insufficiency, leading tomalabsorption and
failure to thrive and impaired mucociliary clearance, leading to re-
current chest infections and bronchiectasis. Advances in the treat-
ment of this disease have resulted in a marked increase in survival
rates over the past three decades and individuals can now be ex-
pected to live into their fourth decade (Dodge 2007). Nonethe-
less, CF remains a progressive disease involving a complex regimen
of daily treatment including high fat, high calorie dietary intake,
pancreatic enzyme replacement, vitamin supplementation, chest
physiotherapy, nebulizedmedication, and antibiotic therapy in the
event of respiratory infection. This daily regimen places consid-
erable responsibility on patients and family members (especially
parents of children and adolescents) to implement treatment re-
quirements in an effort to optimise health and slow down disease
progression.
Description of the intervention
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The role that individuals with CF and family members play in the
active management of their care is now seen as important for in-
creasing the likelihood of positive health outcomes (Savage 2007;
Sawicki 2007; Williams 2007). A number of self-management
education interventions for patients with CF and their families,
or both, have been developed since the 1990s (e.g. Bartholomew
1991; Bartholomew 1997; Downs 2006). Self-management can
be described as helping patients and their families to choose, mon-
itor and adjust treatment requirements for their illness, and also
manage the effects of illness on their lives. The aim is to help them
achieve the best possible health, and to fit treatment requirements
into their everyday activities around a flexible management plan.
The role of health care professionals is to support patients and
families in this task (Newman 2004).
How the intervention might work
In order to make a difference, self-management education inter-
ventions should help patients and families to solve problems, set
goals, and then plan changes in the ways they behave, so that they
are motivated to manage their illness in the best possible way to-
ward optimumhealth outcomes (Lorig 2003; Schreurs 2003). Tra-
ditionally, patient education programmes typically provided dis-
ease-specific knowledge aimed at increasing compliance withmed-
ical treatment and healthcare professional advice (Lorig 2002). In
contrast, self-management education interventions should equip
patients and families with knowledge, confidence, and skills to
take responsibility for daily decisions concerning their health and
to take effective control over managing the demands of chronic
illness in ways that are flexible and relevant to their lives (Lorig
2002). Self-management education should work in ways that posi-
tion patients and their families as ’experts’ working in partnership
with health care professionals (Department of Health 2001).
Why it is important to do this review
Although self-management education interventions for patients
with CF or family members, or both, continue to be developed
and advocated, there remains uncertainty over the effects of these
interventions and to date no previous systematic review of the
evidence has been conducted.
O B J E C T I V E S
To assess the effects of self-management education interventions
on improving health outcomes for patients with CF and their
caregivers.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials, quasi-randomised controlled trials
and controlled clinical trials. Both published and unpublished
studies were considered and no language restrictions were applied.
Types of participants
Individuals of all ages with a diagnosis of CF (diagnosed clinically
and by sweat or genetic testing) or family members, or both.
Types of interventions
Self-management education programmes designed to help pa-
tients, of any age group, or family members, or both, to solve
problems, set goals, and to plan how best to manage treatment
requirements of CF in their daily lives. Education programmes
were only included if a focus on self-management was explicitly
specified in the aims of the programme or the content of the pro-
gramme, or both. Programmes involving any structured educa-
tional or instructional approach were considered, e.g. web-based
learning; computer-aided programme; video or audiotapes; writ-
tenmaterials; one-to-one or group educational sessions. The inter-
ventions included, but were not limited to, self-management edu-
cation designed to assist patients or their caregivers or bothwith di-
etary management including pancreatic enzyme replacement and
vitamin supplementation, physiotherapy techniques and exercises;
and medication management.
The following comparisons were considered:
1. a self-management education intervention versus another
self-management educational intervention;
2. a self-management education intervention versus no
intervention;
3. a self-management education intervention versus ’standard
treatment’.
Types of outcome measures
Primary outcomes
1. Pulmonary function (analysed as per cent predicted)
i) forced expiratory volume at one second (FEV1)
ii) forced vital capacity (FVC)
iii) residual volume/total lung capacity (RV/TLC)
iv) forced expiratory flow 25-75% (FEF25−75%)
2. Indices of nutritional health or growth
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i) change in height
ii) change in weight
iii) body mass index (BMI)
iv) z score
v) any other indices of nutritional health
Secondary outcomes
1. Self-management behaviour: any measure of the abilities of
the patient (or family member, or both) to fit treatment
requirements for CF into their everyday activities. For the
purpose of this systematic review, we included measures of self-
management skills (e.g. monitoring symptoms, monitoring
calorie intake, regulating pancreatic enzymes according to fat
content of food, performance of breathing techniques; goal
setting and planning care; communicating about illness or
aspects of care). We also included measures of independence,
self-efficacy, coping, problem solving.
2. Adherence to CF treatment requirements: any measure of
the patient’s or family member’s, or both, adherence including
pill counts, self-report forms, diaries, electronic monitoring,
prescription refill history.
3. Knowledge: any measure of the patient’s or family
member’s, or both, knowledge of CF and its management.
4. Health-related quality of life: generic or disease-specific, or
both; physical, psychological, social, cognitive, school
functioning.
5. Utilisation of health services: e.g. number of acute
hospitalisations, average length of hospital stay, clinic
appointments (scheduled and unscheduled), number of visits to
general practitioner, number of respiratory exacerbations
requiring systemic antibiotics.
Search methods for identification of studies
Electronic searches
We identified relevant trials from theGroup’s Cystic Fibrosis Trials
Register using the terms: educat* OR program* OR ’self care’ OR
self-care OR selfcare OR self-management OR ’self management’.
The Cystic Fibrosis Trials Register is compiled from electronic
searches of the Cochrane Central Register of Controlled Trials
(Clinical Trials) (updated each new issue ofThe Cochrane Library),
quarterly searches of MEDLINE, a search of EMBASE to 1995
and the prospective handsearching of two journals - Pediatric Pul-
monology and the Journal of Cystic Fibrosis. Unpublished work was
identified by searching the book of abstracts of three major cystic
fibrosis conferences: the International Cystic Fibrosis Conference;
the European Cystic Fibrosis Conference and theNorth American
Cystic Fibrosis Conference. For full details of all searching activi-
ties for the register, please see the relevant sections of theCochrane
Cystic Fibrosis and Genetic Disorders Group Module.
Date of the last search of theCochrane Cystic Fibrosis andGenetic
DisordersGroupCystic Fibrosis Trials Register: 23 February 2011.
We also undertook separate searches of the following databases:
CINAHL with full text (EBSCO) (Appendix 1); Psychologi-
cal and Behavioural Sciences Collection (EBSCO) (Appendix
2); PsycINFO (EBSCO) (Appendix 3); SocINDEX (EBSCO)
(Appendix 4); Embase (Elsevier) (Appendix 5). No language re-
strictions were applied to separate searches of databases.
Date of the last search of each of these databases: 30th March
2011.
Searching other resources
Reference lists of relevant trials identified were examined for addi-
tional citations. Specialists in the field and authors of the included
trials were contacted to identify possible unpublished data.
Data collection and analysis
Selection of studies
To identify potentially eligible trials, two authors (ES, PB) inde-
pendently screened the titles and abstracts of all reports gleaned
through the search strategy. Where it was not possible to tell from
the title and abstract whether a study was potentially eligible for
inclusion, the authors retrieved full text copies of the studies. We
applied no language restrictions to our search strategy.We planned
to have any papers written in a foreign language translated prior to
evaluating eligibility for inclusion if this could not be determined
from the title and abstract (if available in the English language),
or if an abstract was not available. We identified one non-Engligh
paper (French) (David 2008). One author (MNiC), who is fluent
in this language, translated this paper. Two authors (ES, PB) in-
dependently read full text copies of all trials appearing to meet the
inclusion criteria to determine their eligibility for inclusion in the
review. We resolved any disagreements by discussion. If resolution
was not possible, we planned to consult the other members of
review team to adjudicate and reach consensus, however, this was
not necessary.
Data extraction and management
For all trials that met the inclusion criteria, one author (ES) ex-
tracted data, two authors (PB, DF) independently cross-checked
these. We resolved discrepancies by discussion. If needed, we
planned to consult the other members of review team to resolve
any disagreements. We used a standardised form adapted from
the checklist of items in Table 7.3a in the Cochrane Handbook for
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Systematic Reviews of Interventions (Higgins 2011a), to extract data
from each trial:
• general information (e.g. title, authors, citation and contact
details);
• methods (trial design, randomisation process and other
concerns about bias, study duration);
• participants (total number and flow of participants through
trial, reasons for attrition, sample size estimations, settings,
severity of illness, age and sex, details on co-morbidity);
• interventions (description of intervention including its
content, mode of delivery, duration, setting, number of groups,
treatment of controls);
• outcomes (primary and secondary outcomes relevant to this
review, measures used, time points of data collection, intention
to treat analysis);
• results (for each outcome - sample size, number of missing
participants, summary data for each intervention group, estimate
of effect, and subgroup analyses);
• miscellaneous (funding source, key conclusions by study
authors, references to other relevant articles).
A third author (DF) cross-checked data on number of participants,
mean scores and standard deviations (SD) entered into RevMan
for each outcome against the data extraction forms and published
records (RevMan 2011). We contacted trial authors for informa-
tion either missing or unclear in published records. Where pos-
sible, we grouped outcome data into those measured at 1 to 6
months, 7 to 12 months, 13 to 18 months, 19 to 24 months and
6 monthly intervals after these time points if applicable.
Assessment of risk of bias in included studies
Two authors (ES, PB) assessed each of the included trials for risk
of bias and disagreements were resolved through discussion with-
out the need to consult other members of the review team. We
assessed the risk of bias using the six specific domain-based evalu-
ation criteria as described in the Cochrane Handbook for System-
atic Reviews of Interventions 5.1 (Higgins 2011b). These were se-
quence generation, allocation concealment, blinding, incomplete
outcome data, selective outcome reporting, and other sources of
bias. For ’other sources of bias’ we assessed efforts at minimizing
cross-contamination bias (i.e. unofficial delivery of any aspect of
the intervention to the ’control’ group) including selecting inter-
vention and control groups from different CF centres, asking par-
ticipants in the ’control’ group not to access or use self-manage-
ment education material from sources such as the Internet, other
CF families, CF organisations; asking participants in intervention
group not to discuss the intervention with others until the end
of the study; asking the control group what information about
managing CF they have accessed during the course of the study.
In evaluating the risk of bias for each of the six domains within
each study included in the review, we made a judgement of ’low
risk’, ’high risk’ or ’unclear risk’ on the following basis:
1. ’low risk’ of bias if the description of a domain indicated
that it was adequately addressed;
2. ’high risk’ of bias if the description of a domain indicated
that it was not adequately addressed;
3. ’unclear risk’ of bias if insufficient detail about a domain
was reported.
Measures of treatment effect
To assess differences between groups, we recorded post-treatment
mean difference (MD) values with 95% confidence intervals (CI)
as our treatment effect measure for continuous variables. For di-
chotomous outcomedata, we planned to assess treatment effects by
calculating risk ratios (RR) with 95% confidence intervals (CIs).
However, the trials included in this review only reported contin-
uous outcome data.
Unit of analysis issues
For longitudinal measurements, we analysed data at each assess-
ment time-point post treatment.
Dealing with missing data
To allow an intention-to-treat analysis, we planned to seek data on
the number of participants with each outcome event, by allocated
treated group, irrespective of adherence and whether or not the
individual was later thought to be ineligible or otherwise excluded
from treatment or follow-up. We contacted primary authors of
trials to clarify data where necessary or to advise on data missing
from published papers. We have listed the authors who replied
to our requests for further information in the Acknowledgements
section.
Assessment of heterogeneity
We planned to pool the results of studies only if they were judged
to be sufficiently similar in terms of populations, interventions
and outcomes. We planned to measure the inconsistency of trial
results using I2 statistic to determine if variation in outcomes across
trials was due to heterogeneity rather than occurring by chance
(Deeks 2011). The I2 statistic quantifies heterogeneity in terms
of overlapping percentage intervals: 0% to 40% (might not be
important); 30% to 60% (may representmoderate heterogeneity);
50% to 90% (may represent substantial heterogeneity); and 75%
to 100% (considerable heterogeneity) (Deeks 2011).
Assessment of reporting biases
We planned to assess funnel plot asymmetry for publication biases
and other causes. However, this was not possible because tests for
funnel plot asymmetry are not recommended unless there are at
least 10 trials included in a meta-analysis (Sterne 2011).
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Data synthesis
If we had identified studies as being clinically (e.g. similar age
groups) or methodologically (e.g. similar interventions) homoge-
nous but statistically heterogeneous, we planned to conduct a
random-effects meta-analysis. However, we did not conduct any
meta-analysis in this review since studies were either clinically or
methodologically diverse (or both). Conducting a meta-analysis
on data from diverse studies runs the risk of obscuring genuine
differences in effect (Deeks 2011). For future updates of this re-
view, we will continue to plan for meta-analysis if appropriate. A
narrative synthesis of the data is currently presented.
Subgroup analysis and investigation of heterogeneity
If we had identified substantial heterogeneity and included a suf-
ficient number of trials, we planned to conduct subgroup analyses
to investigate possible reasons for variations in results across trials.
For subgroup analyses, we planned to make comparisons between
subsets of participants, subsets of interventions, subsets of settings
in which interventions were delivered, and subsets of personnel
delivering interventions. We planned to stratify studies into:
1. participant age-group subsets (infants and toddlers up to
two years, pre-school children aged 2 years to 5 years, primary
school children aged 6 years to 12 years, adolescents aged 13
years to 17 years, adults aged 18 years and over);
2. intervention type (e.g. web-based learning, computer-aided
programme, written materials, etc) and duration;
3. settings in which intervention was conducted (e.g. home,
hospital, school);
4. personnel delivering intervention (e.g. dietitians, nurses,
physicians, physiotherapists, CF advocacy or voluntary groups).
In future updates of this review, we will continue to adopt this
plan for subgroup analysis and investigation of heterogeneity.
Sensitivity analysis
If appropriate, we planned to conduct sensitivity analysis to deter-
mine the influence on effect size of: published and unpublished
trials; risk of bias as outlined above; length and size of studies.
However, there were insufficient studies to perform this analysis.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of studies awaiting classification.
Results of the search
A total of 123 records were identified through our search strategy
as potentially relevant for inclusion. Of these, 35 citations report-
ing on 23 studies were identified by a search of the Cystic Fibrosis
and Genetic Disorders Group’s CF Trials Register. An additional
87 records were identified from our search of individual databases.
One additional record was identified in a newsletter published in
Cystic Fibrosis Worldwide.Of the 123 records examined, a total of
11 records reporting on four trials were identified as meeting the
inclusion criteria (Cottrell 1996; Downs 2006; Stapleton 2001;
Watson 2008). Seven additional records (on six studies) were iden-
tified as potentially eligible for inclusion and are awaiting clas-
sification (Bergman 2007; Cannon 1999; Jessup 2008; Johnson
2001; Van der Gieesen 2006; Wainwright 2009). The remaining
103 records were excluded.
Included studies
The four included trials were published in peer-reviewed jour-
nals (Cottrell 1996; Downs 2006; Stapleton 2001;Watson 2008).
Multiple records for three of the trials were identified: one was re-
ported in three journal articles (Stapleton 2001); one was reported
in four conference proceeding abstracts and one journal article
(Watson 2008); and one was reported in an unpublished thesis
and in a journal article (Cottrell 1996). For multiple records, data
were extracted from the most recent publication and then from
earlier publications as necessary.
Trial design
All four trials were of parallel design. Three trials were conducted
in a single centre (Cottrell 1996; Stapleton 2001; Watson 2008).
One trial was multicentre involving CF clinics of three public
hospitals (Downs 2006).Two trials were undertaken in Australia
(Downs 2006; Stapleton 2001); one in the USA (Cottrell 1996)
and one in the UK (Watson 2008).
Participants
A total of 368 participants were recruited and randomised across
the four trials: 139 children with CF; 155 caregivers of children;
and 74 adults with CF. A total of 269 participants completed
the trials: 104 children; 117 parents/carergivers (Cottrell 1996;
Downs 2006; Stapleton 2001); and 48 adults (Watson 2008).
1. Children
Children with CF were included in three trials, aged 8 years to 18
years in one trial (Cottrell 1996), and 6 years to 11 years in two
trials (Downs 2006; Stapleton 2001).
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2. Caregivers/parents
Caregivers of children were included in three trials (Cottrell 1996;
Downs 2006; Stapleton 2001). Caregivers were explicitly stated as
parents in one trial (Cottrell 1996) and as the adult most respon-
sible for managing children’s nutrition in another trial (Stapleton
2001). It was not explicitly stated who the caregivers were in one
trial (Downs 2006).
3. Adults
Adults with CF were aged 16 years to 43 years. None of the adults
were waiting on a “heart/lung transplant list or were pregnant or
lactating” at the time of taking part in the trial (Watson 2008).
Interventions
1. A self-management education intervention versus another
self-management educational intervention
No included trial made this comparison.
2. A self-management education intervention versus no
intervention
No included trial made this comparison.
3. A self-management education intervention versus
’standard treatment’
The four included trials made this comparison.
a. Self-management training programme versus standard
treatment
One trial evaluated the effects of a self-management training pro-
gramme in reducing the impact of CF on children and parents
(Cottrell 1996). The programme was delivered in two six-hour
group sessions in a hospital setting, facilitated by a registered nurse
or psychologist. In the group sessions, knowledge of the nature
of CF, principles of self-management, and strategies for manag-
ing CF-related problems were addressed. Skills training included
problem solving and stress management.
b. Self-management education on aerosol and airway
clearance treatments (’Airways’) versus standard treatment
One trial evaluated the effects of an education programme (’Air-
ways’) on the self-management of aerosol and airway clearance
treatments (Downs 2006). The ‘Airways’ programme was home
based using writtenmaterial containing child friendly information
and behavioural exercises. Over a period of 10 weeks, children and
their caregivers completed weekly exercises, each lasting approx-
imately 20 minutes. The knowledge content of the programme
drew on disciplines of medicine, physiotherapy, psychology and
education. Self-management skills addressed in the programme
were assessment, treatment implementation, decisionmaking, and
strategies to overcome barriers to treatment.
c. Nutrition self-management education versus standard
treatment
Two trials made this comparison focusing on either disease-spe-
cific nutrition education (Stapleton 2001) or general and disease-
specific nutrition education (Watson 2008).
i. Sub-comparison: Disease-specific nutrition education (’Go and
Grow with CF’) versus standard treatment
One trial evaluated the effects of a nutrition education programme
(’Go and Grow with CF’) on disease-specific nutrition knowl-
edge and self-management skills (Stapleton 2001). The ’Go and
Grow with CF’ programme was home based using child-friendly
written material on nutrition management. Over a period of 10
weeks, children and their caregivers completed weekly exercises,
each lasting approximately 60 minutes. The programme included
supplementary introductory and concluding workshops for sep-
arate groups of children and caregivers in a hospital setting, fa-
cilitated by dietitians. Knowledge content of the programme in-
cluded disease-specific nutrition topics: enzymes; energy and fat;
malabsorption; vitamins and minerals; growth; snacks; and salt.
Self-management skills addressed in the programme were goal set-
ting in small incremental steps to increase self efficacy, and self-
monitoring adherence to daily goals.
ii. Sub-comparison: General and disease-specific nutrition educa-
tion (’Eat Well with CF’) versus standard treatment
One trial evaluated the effects of a nutrition education programme
(’EatWell withCF’) on general anddisease-specific knowledge and
self-management skills training (Watson 2008). The ’Eat Well for
CF’ programme was home-based using written materials. Over a
period of 10 weeks, participants completed weekly activities, each
lasting approximately 30 minutes. Knowledge content of the pro-
gramme included general and disease-specific nutrition topics: en-
ergy intake; digestion; pancreatic enzyme replacement; managing
appetite; exercise; dietary fibre; reading food labels; body image.
Self-management skills included goal setting in small incremental
steps to establish new behaviours.The programme included sup-
plementary group workshops (introductory weeks 5 and 10) in
a hospital setting and weekly telephone calls, facilitated by dieti-
tians. During the course of the trial, microbiological segregation
was introduced following which workshops could no longer be
held. Consequently, the trial was terminated.
Outcomes
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Only outcomes of trials comparing ’Self-management education
intervention versus standard treatment’ are reported since no trials
were identified for the remaining two comparisons groups consid-
ered in this review.
3. Self-management education intervention versus ’standard
treatment’
a. Self-management training programme versus standard
treatment
In the one trial that made this comparison, one primary and four
secondary outcomes relevant to this review were assessed (Cottrell
1996). Only our pre-defined outcomes that were reported in the
included trials are listed below.
Primary outcomes
2. Indices of nutritional health or growth
Change in weight was measured in pounds using participants’
home scales (Cottrell 1996).
Secondary outcomes
1. Self-management behaviour
The number and frequency of both children’s and parent’s be-
haviours in relation to managing digestive and pulmonary system
problem areas were assessed using previously established question-
naires. The number of self-management behaviours thatwere done
’at least sometimes’ were recorded out of a total of 21 digestive
system problem areas and a total of 26 pulmonary system problem
areas. The maximum total score for self-management behaviour
was 47. For each of the 47 self-management behaviours, frequency
of performance was rated on a four-point scale ranging from 0 =
never to 4 = always. An average of the response scores provided
an overall frequency score ranging between zero and four (Cottrell
1996).
2. Adherence
Medications and aerosol treatment taken by children as well as the
number of chest physiotherapy sessions were assessed using a self-
report diary. It was unclear whether children or parents completed
the diary. Percentage ’compliance’ was computed for each aspect of
treatment by comparing reported ’compliance’ with the schedule
prescribed by physicians (Cottrell 1996).
3. Knowledge
Knowledge was assessed using an established ‘CF Knowledge Sur-
vey’ consisting of multiple-choice questions for children, adoles-
cents, and parents. The percentage of correct answers from each
participant was recorded (Cottrell 1996).
4. Health-related quality of life
Children’s quality of life was measured using the ‘quality of well-
being scale’ comprising three sub scales of functioning (mobility,
physical activity, social activity) and twenty two problems/symp-
toms that could impair function. The total quality of life score
ranged from zero (dead) to one (optimal functioning) (Cottrell
1996).
All outcomes were assessed at baseline and at six- to eight-week
follow-up. Results for all outcomes were expressed as means and
SDs (Cottrell 1996).
b. Self-management education on aerosol and airway
clearance treatments (’Airways’) versus standard treatment
In the one trial that made this comparison, three secondary out-
comes relevant to this review were assessed (Downs 2006).
Secondary outcomes
1. Self-management behaviours
Self-management behaviours of caregivers relating to aerosol and
airway clearance treatments were assessed. Caregivers completed
a newly developed one-week diary card constructed around three
self-management sub scales: assessment; treatment; and commu-
nication. The unit of measure was a fractional score with one being
the best possible score (Downs 2006).
Self-management responsiveness of caregivers to airway clearance
treatment during children’s unwell days was recorded. The per-
formance of longer and additional airway clearance treatment was
considered to be responsive to the child’s treatment needs. A mean
responsiveness score for all unwell days was calculated (Downs
2006).
Self-efficacy of caregivers to manage airway clearance treatments
was assessed using an established ‘self-efficacy scale’ with five being
the best possible score (Downs 2006).
2. Adherence
Adherence to aerosol and airway clearance treatment was reported
by caregivers in a one-week diary and was measured as a percentage
of prescribed treatments taken by children (Downs 2006).
3. Knowledge
Children’s knowledge on airway clearance treatment was assessed
using a newly developed questionnaire with 23 being the best
possible score (Downs 2006).
In this trial, adherence, self-management behaviours (assessment,
treatment, communication) and self-efficacy were assessed at base-
line, at immediate post test, and at 6- and 12-month follow-up.
Self-management responsiveness was assessed at baseline and at
post test. Knowledge was assessed at baseline, post test and at 12-
month follow-up. Results for all outcomeswere expressed asmeans
and SDs (Downs 2006).
c. Nutrition self-management education versus standard
treatment
i. sub-comparison: Disease-specific nutrition education (’Go and
Grow with CF’) versus standard treatment
In the one trial that made this sub-comparison, two secondary
outcomes relevant to this review were assessed (Stapleton 2001).
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Secondary outcomes
1. Self-management behaviours
Self-management skills of both children and caregivers were as-
sessed using scenarios designed to yield open responses categorised
as appropriate or inappropriate. For children, scenarios related to
signs of malabsorption and communicating to caregivers about
nutritional management; the highest possible scores being 23 for
appropriate responses and five for inappropriate responses. For
caregivers, scenarios related to malabsorption and assessment of
what age they expected their children to manage their own pan-
creatic enzyme replacement therapy. The highest possible scores
for caregivers were 61 for appropriate responses and 41 for inap-
propriate responses (Stapleton 2001).
3. Knowledge
Nutritional and enzyme knowledge was assessed using similar but
separate newly developed questionnaires for children and care-
givers. Each correct response was allocated a score of one. For
children, the best possible score was 37. For caregivers, the best
possible score was 42 (Stapleton 2001).
All outcomes in this trial were assessed at baseline, at immediate
post-test, and at 12 month follow-up. Results for all outcomes
were reported as mean score change and standard error (SE) values
from baseline (Stapleton 2001). On request, the author provided
unpublished data on mean differences and SEs for intervention
effects.
ii. sub-comparison: General and disease-specific nutrition education
(’Eat Well with CF’) versus standard treatment
In the one trial that made this sub-comparison, two primary out-
comes and three secondary outcomes relevant to this review were
assessed (Watson 2008).
Primary outcomes
1. Pulmonary function
Watson assessed FEV1 analysed as per cent predicted (Watson
2008).
2. Indices of nutritional health or growth
Change inweight was assessed in kilograms using the samemedical
weighing scale for all participants (Watson 2008).
Dietary fat intake was assessed using a 17-item self-reported food
frequency questionnaire, yielding a maximum score of sixty three
points as the best possible score (Watson 2008).
Secondary outcomes
1. Self-management behaviour
Self-efficacy of adults to cope with a special diet was assessed using
a newly developed measure, with 27 being the best possible score
(Watson 2008).
3. Knowledge
Disease-specific and general nutrition knowledge were assessed us-
ing separate questionnaires adapted from previously established
questionnaires designed for adults; the highest possible scores be-
ing 55 for disease-specific knowledge and 21 for general knowl-
edge (Watson 2008).
4. Health-related quality of life
Quality of life was assessed using an established disease-specific
measure for adults comprised of nine CF-specific domains (phys-
ical functioning, social functioning, treatment issues, chest symp-
toms, emotional responses, concerns for the future, interpersonal
relationships, body image, career issues). The best possible health-
related quality of life score that could be attained was 100 (Watson
2008).
All outcomes in this trial were assessed at baseline, and at 6- and12-
month follow-up. Results for all outcomeswere expressed asmeans
and SDswith the exception of quality of life, which were presented
as differences in scores for each domain between intervention and
control group (Watson 2008).
Excluded studies
Of the 123 records examined, 62 records were excluded follow-
ing a review of title and abstracts because they were: review pa-
pers; reported on practice initiatives and were not studies; reported
on instrument development; were clearly not education interven-
tions; or did not include participants with CF. An additional 44
records (reporting on 23 studies) were excluded following review
of abstracts and related full text publications because theywere not
RCTs, quasi-RCTs or CCTs or did not explicitly address self-man-
agement education in the aims or content of the programme. De-
tails of the 23 excluded studies are presented in the Characteristics
of excluded studiestable.
Missing data
The principal authors of the four included trials were contacted
for information missing from published records. Missing data in
the four trials related mainly to criteria for assessing risk of bias
Three authors provided additional information (Stapleton 2001;
Downs 2006; Watson 2008). Details of missing data are provided
in the Characteristics of included studies table.
Studies awaiting classification
Six studies await classification, five of which were published as
abstracts (Cannon 1999; Jessup 2008; Johnson 2001; Van der
Gieesen 2006; Wainwright 2009). The remaining study was pub-
lished in the Cystic Fibrosis Worldwide Newsletter targeting a lay
and professional audience (Bergman 2007). All studies are await-
ing classification because insufficient details on characteristics of
the studies are available, and data on outcomes could not be ex-
tracted from publications in the format required for analysis. The
principal authors of five studies have been contacted for further
information (Bergman 2007; Jessup 2008; Johnson 2001; Van der
Gieesen 2006; Wainwright 2009), two of whom have responded
(Johnson 2001; Van der Gieesen 2006). Efforts to locate contact
details on any of the authors concerning one study have failed
(Cannon 1999). Information available to date on the six studies is
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presented in the Characteristics of studies awaiting classification
table.
Risk of bias in included studies
Based on the six domain-based evaluation criteria recommended in
the Cochrane Handbook for Systematic Reviews of Interventions
5.1 (Higgins 2011b), none of the four included trials were judged
as adequately meeting all criteria (Figure 1; Figure 2).
Figure 1. Risk of bias graph: review authors’ judgements about each risk of bias criterion presented as
percentages across all included studies.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias criterion for each
included study.
Please refer to the risk of bias tables for each individual trial located
within the Characteristics of included studies table.
Allocation
Sequence generation was judged to be low risk in three trials (
Downs 2006; Stapleton 2001; Watson 2008) and unclear in one
trial (Cottrell 1996). Allocation concealment was judged to be
unclear in two trials (Cottrell 1996; Stapleton 2001), high risk in
one trial (Downs 2006), and low risk in one trial (Watson 2008).
Blinding
Details on blinding were unclear in the four trials (Cottrell 1996;
Downs 2006; Stapleton 2001; Watson 2008). Blinding of par-
ticipants is not possible for any of the interventions considered,
however in two trials outcome assessors were blinded to at least
some of the outcomes (Downs 2006; Stapleton 2001).
Incomplete outcome data
For incomplete outcome data, one trial was judged to be low risk
(Watson 2008) and unclear in three trials (Cottrell 1996; Downs
2006; Stapleton 2001).
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Selective reporting
One trial was judged to be high risk in terms of being ’free of
selective reporting’ (Stapleton 2001) and unclear in three trials
(Cottrell 1996; Downs 2006; Watson 2008).
Other potential sources of bias
For the criterion on ‘free from other bias’, three trials were deemed
to be low risk (Downs 2006; Stapleton 2001; Watson 2008), and
high risk in one trial (Cottrell 1996).
Effects of interventions
Only the effects of ’a self-management education intervention ver-
sus standard treatment’ are reported since no trials made the re-
maining two comparisons considered in this review. Only our pre-
defined outcomes that have been reported on within the included
trials are listed below. A summary of effects of interventions is
presented in Table 1.
Table 1. Summary of the Effects of Interventions
Self-management training programme versus standard treatment (Cottrell 1996)
Effects of intervention
(Statistically significant results favouring intervention group are presented in bold)
PRIMARY OUTCOME (Children)
Indices of nutritional health or growth
Change in weight
Assessment time points : 6- to 8-weeks follow-up
No statistically significant difference between groups in change in weight: MD -7.74 lb
(95% CI -35.18 to 19.70) (Analysis 1.1).
SECONDARY OUTCOMES (Children)
Self-management behaviours
Number of digestive and pulmonary system
behaviours
Frequency of digestive and pulmonary system
behaviours
Assessment time points : 6 to 8 weeks follow-up
Statistically significantly greater number of digestive behaviours in the standard treatment
group than training group, MD -5.30 (95% CI -9.29 to -1.31) (Analysis 1.2). No
statistically significant difference between groups in the number of pulmonary system
behaviours, MD -1.00 (95% CI -6.31 to 4.31) (Analysis 1.3).
No statistically significant differences between groups for digestive system, pulmonary
system, or both systems combined, MD -0.35 (95% CI -1.05 to 0.35); MD -0.28 (95%
CI -0.90 to 0.34); and MD -0.18 (95% CI -0.81 to 0.45) respectively (Analysis 1.4;
Analysis 1.5; Analysis 1.6)
Adherence
Percentages of medications, aerosol treat-
ments, and chest physiotherapy taken.
Assessment time points : 6- to 8- weeks follow-up
No statistically significant differences between groups in the % of prescribed treatments
takenby children:medicationsMD2.00%(95%CI -16.31 to 20.31); aerosol treatments,
MD 13.00% (95% CI -20.11 to 46.11), and chest physiotherapy, MD -8.00 % (95%
CI -46.13 to 30.13) (Analysis 1.7; Analysis 1.8; Analysis 1.9).
Knowledge Assessment time points: 6- to 8-weeks follow-up
Statsitically significant greater knowledge scores about CF and its management in the
training group than the standard treatment groups, MD 19.25% (95% CI 7.57 to
30.93) (Analysis 1.10).
Health-related quality of life
Quality of well-being
Assessment time points: 6- to 8-weeks follow-up
No statistically significant difference between groups, MD -0.02 (95% CI -0.09 to 0.05)
(Analysis 1.11).
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Table 1. Summary of the Effects of Interventions (Continued)
SECONDARY OUTCOMES (Parents)
Self-management behaviours
Number of digestive and pulmonary system
behaviours
Frequency of digestive and pulmonary system
behaviours
Assessment time points : 6- to 8-weeks follow-up
No statistically significant differences between groups for digestive system, pulmonary
system, or both systems combined, MD -1.00 (95% CI -3.47 to 1.47), MD 0.40 (95%
CI -2.73 to 3.53), and MD -0.60 (95% CI -5.20 to 4.00) respectively (Analysis 1.12;
Analysis 1.13; Analysis 1.14).
No statistically significant differences between groups for digestive system, pulmonary
system, or both systems combined, MD -0.09 (95% CI -0.65 to 0.47); MD 0.02 (95%
CI -0.45 to 0.49); and MD 0.00 (95% CI -0.44 to 0.44) respectively (Analysis 1.15;
Analysis 1.16; Analysis 1.17).
Knowledge Assessment time points: 6- to 8-weeks follow-up
No statistically significant difference between groups, MD 2.11% (95% CI -6.65 to
10.87) (Analysis 1.18).
Self-management education on aerosol and airway treatment clearance education (’Airways’) versus standard treatment (Downs 2006)
.
Effects of intervention
(Statistically significant results favouring intervention group are presented in bold)
SECONDARY OUTCOMES (Children)
Adherence Assessment time points : Post test, 6-months follow-up, 12-months follow-up
Statistically significant greater % of prescribed aerosol treatments taken by ’Airways’
group at each time point (Analysis 2.1): Post testMD29.70% (95%CI 14.29 to 45.11)
; 6-months follow-up MD 21.00% (95% CI 5.59 to 36.41); 12-months follow-up
MD 17.50% (95% CI 5.50 to 29.50) .
Statistically significant greater % of prescribed airway clearance treatments taken by
’Airways’ group significantly greater at 6-months follow-up only (Analysis 2.2): Post test
MD 19.00% (95% CI -0.62 to 38.62); 6 months follow-up MD 21.60% (CI 95%
7.04 to 36.16); 12-months follow-upMD 15.10% (95% CI -3.18 to 33.38).
Knowledge Assessment time points : Post test, 12-months follow-up
Significantly greater knowledge scores in the ’Airways’ group at each time point (Analysis
2.3): Post testMD 3.80 (95% CI 2.29 to 5.31); 12-months follow-upMD 4.60 (95%
CI 2.83 to 6.37).
SECONDARY OUTCOMES (Caregivers)
Self-management behaviours
Assessment behaviour
Treatment behaviour
Communication behaviour
Responsiveness to airway clearance treatments
on children’s unwell days
Self-efficacy to manage airway clearance
treatments
Assessment time points : Post test, 6 months follow-up, 12 months follow-up
Statistically significant greater assessment behaviour scores in the ’Airways’ group post
test only (Analysis 2.4): Post test MD 0.17 (95% CI 0.02 to 0.32); 6 months follow-
up MD 0.15 (95% CI -0.01 to 0.31); 12 months follow-up MD 0.08 (95% CI -0.06
to 0.22).
Statistically significant greater treatment behaviour scores in the ’Airways’ group at 6
month only (Analysis 2.5): Post test MD 0.07 (95% CI -0.01 to 0.15); 6 months follow-
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